1. OP006 Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study. (16th January 2018) Authors: Danese, S; Neurath, M; Kopon, A; Zakko, S; Simmons, T; Fogel, R; Maccarone, J; Zhan, X; Usiskin, K; Chitkara, D Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗